中国生物技术、癌症早筛领域前景广阔_OK阅读网
双语新闻
Bilingual News


双语对照阅读
分级系列阅读
智能辅助阅读
在线英语学习
首页 |  双语新闻 |  双语读物 |  双语名著 | 
[英文] [中文] [双语对照] [双语交替]    []        


中国生物技术、癌症早筛领域前景广阔
Nation sees big biz in biotech, early cancer detection

来源:中国日报    2022-06-20 17:17



        If you ask anyone how to reduce the mortality rate of cancer patients, the answer may vary from person to person. Yet early detection and intervention probably will occur in most people's answers to that question.如何降低癌症患者的死亡率,对此人们的回答可能有所不同。然而,大多数人的答案可能都包括早期发现和干预。
        Thanks to population aging and policy support, together with growing public awareness, the early cancer screening market in China will continue to expand, and domestic enterprises are expected to further strengthen their innovation and commercialization capabilities, experts and business leaders said.专家和商界领袖表示,由于人口老龄化和政策支持,加上公众意识的不断提高,中国早癌筛查市场将继续扩大,预计国内企业将进一步加强其创新和商业化能力。
        "Chinese authorities have reiterated on various occasions the importance of early detection and intervention for the prevention and control of cancer. The market prospects are very promising," he said.史立臣称:“中国官方多次强调早期发现和干预对预防和控制癌症的重要性。早癌筛查市场前景十分光明。”
        A report by early detection information provider Zao Dx said 26 financing events were announced last year in China's early cancer detection industry, among which 15 came at more than 100 million yuan ($14.92 million) each. The combined value of financing reached more than 6.6 billion yuan last year.早筛网的一份报告称,2021年中国早癌筛查行业宣布了26项融资活动,其中15项融资活动的金额均超过1亿元人民币,2021年融资总额超过66亿元。
        In particular, the application of liquid biopsy technology based on high-throughput sequencing has greatly increased the probability of the detection and early intervention of cancer, he said.周珺称,基于高通量测序的液体活检技术的应用大大提高了癌症检测和早期干预的可能性。
        However, analysts said large-scale rollouts of early cancer screening in China require improvements in not only cancer screening technology and policy support, but also in payments, clinical applications and regulations to spur the commercialization of related products.然而,分析人士表示,中国大规模开展早癌筛查不仅需要改进癌症筛查技术和政策支持,还需要完善支付、临床应用和监管,以推动相关产品的商业化。
        "Yet the differences will present themselves among the capabilities to commercialize products," Shi said, adding major obstacles Chinese enterprises face for successful commercialization mainly include not only how to improve product efficacy and reduce pricing, but also how to get included in public or commercial medical insurance programs.“然而,差异表现在产品商业化的能力上,中国企业成功商业化面临的主要障碍不仅包括如何提高产品功效和降低价格,还包括如何加入公共或商业医疗保险计划。”
        A report by VCBeat Research said about 70 percent of Chinese cancer patients are already at the middle-to-late stage of the disease when they seek medical advice for the first time.动脉网的一份报告显示,约70%的中国癌症患者在首次就诊时已经处于疾病的中晚期。
         
        
   返回首页                  

OK阅读网 版权所有(C)2017 | 联系我们